Stock Events

Stock Events

XBiotech 

$2.28
137
-$0.03-1.3% 18:14 Today

Statistics

Day High
2.32
Day Low
2.26
52W High
3.61
52W Low
2.09
Volume
9,470
Avg. Volume
33,840
Mkt Cap
69.51M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 21
$2.10
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.88
-0.61
-0.33
-0.06
Expected EPS
N/A
Actual EPS
-0.88

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-38.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XBIT. It's not an investment recommendation.
Apple
13
AAPL
Star Bulk Carriers
13
SBLK
Realty Income
12
O
Tesla
12
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals competes in the biotechnology field, focusing on immunology and inflammatory diseases, similar to XBiotech's focus on True Human antibody therapies.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotech firm that develops innovative human therapeutics, including treatments for conditions in areas that XBiotech targets, making them direct competitors.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, overlapping with XBiotech's market.
Biogen
BIIB
Mkt Cap31B
Biogen focuses on neurology and rare diseases but also has a portfolio in immunology, competing with XBiotech in the broader biotech and therapeutic antibodies market.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie operates in the same biopharmaceutical field as XBiotech, with a strong emphasis on immunology and oncology, areas where XBiotech also aims to innovate.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals in various areas, including immunotherapy, where XBiotech is also striving to make advancements.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a large pharmaceutical company with a diverse portfolio, including immunology and oncology, competing with XBiotech in the development of novel treatments.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in the same therapeutic areas as XBiotech, including immunology and oncology.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb is focused on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, including areas where XBiotech is active.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company that operates in various segments, including innovative medicines in areas like immunology, directly competing with XBiotech's research and development focus.

About

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Show more...
CEO
Sushma Shivaswamy
Employees
87
Country
United States
ISIN
CA98400H1029
WKN
000A14QF1

Listings

STU
DE
4XB.STU
MU
DE
4XB.MU
F
DE
4XB.F
BOATS
BOATS
XBIT.BOATS

0 Comments

Share your thoughts

FAQ

What is XBiotech stock price today?▼
The current price of XBIT is $2.28 USD — it has decreased by -1.3% in the past 24 hours. Watch XBiotech stock price performance more closely on the chart.
What is XBiotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange XBiotech stocks are traded under the ticker XBIT.
Is XBiotech stock price growing?▼
XBIT stock has risen by +0% compared to the previous week, the month change is a +2.68% rise, over the last year XBiotech has showed a -28.13% decrease.
What is XBiotech market cap?▼
Today XBiotech has the market capitalization of 69.51M
What were XBiotech earnings last quarter?▼
XBIT earnings for the last quarter are -0.88 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is XBiotech revenue for the last year?▼
XBiotech revenue for the last year amounts to 0 USD.
What is XBiotech net income for the last year?▼
XBIT net income for the last year is -38.53M USD.
Does XBiotech pay dividends?▼
Yes, XBIT dividends are paid en. The last dividend per share was 2.1 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does XBiotech have?▼
As of August 21, 2026, the company has 87 employees.
In which sector is XBiotech located?▼
XBiotech operates in the Health & Wellness sector.
When did XBiotech complete a stock split?▼
XBiotech has not had any recent stock splits.
Where is XBiotech headquartered?▼
XBiotech is headquartered in AUSTIN, United States.